APA (7th ed.) Citation

Bastholt, L., Schmidt, H., Bjerregaard, J. K., Herrstedt, J., & Svane, I. M. (2019). Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma. European Journal of Cancer, 119, 122. https://doi.org/10.1016/j.ejca.2019.06.022

Chicago Style (17th ed.) Citation

Bastholt, Lars, Henrik Schmidt, Jon Kroll Bjerregaard, Jørn Herrstedt, and Inge Marie Svane. "Age Favoured Overall Survival in a Large Population-based Danish Patient Cohort Treated with Anti-PD1 Immune Checkpoint Inhibitor for Metastatic Melanoma." European Journal of Cancer 119 (2019): 122. https://doi.org/10.1016/j.ejca.2019.06.022.

MLA (9th ed.) Citation

Bastholt, Lars, et al. "Age Favoured Overall Survival in a Large Population-based Danish Patient Cohort Treated with Anti-PD1 Immune Checkpoint Inhibitor for Metastatic Melanoma." European Journal of Cancer, vol. 119, 2019, p. 122, https://doi.org/10.1016/j.ejca.2019.06.022.